Control the Media? No, Educate Them

Ignorance and commercial interest make a combustible mixture, with enlightenment often a victim of the fumes. Views tend to polarize and become unduly influenced by those best able to manipulate the media, irrespective of the argument's merits. The result can be an alarming disparity between public opinion and the true state of the science. No doubt, this syndrome has adversely affected debate over big issues such as genetic modification of plants and global warming. The question is, what's

Written byPhilip Hunter
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Ignorance and commercial interest make a combustible mixture, with enlightenment often a victim of the fumes. Views tend to polarize and become unduly influenced by those best able to manipulate the media, irrespective of the argument's merits. The result can be an alarming disparity between public opinion and the true state of the science.

No doubt, this syndrome has adversely affected debate over big issues such as genetic modification of plants and global warming. The question is, what's to be done? Awareness alone does not lead to enlightenment, and to an extent the public are at the mercy of what they read and hear. Such consideration has led the UK government to introduce what is, in effect, a form of censorship. The government, in justifying its new stance, blames the opinion shapers, the media, calling for more accurate and balanced scientific reporting.

The UK government has introduced guidelines for scientific ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies